Cargando…

AMPDeep: hemolytic activity prediction of antimicrobial peptides using transfer learning

BACKGROUND: Deep learning’s automatic feature extraction has proven to give superior performance in many sequence classification tasks. However, deep learning models generally require a massive amount of data to train, which in the case of Hemolytic Activity Prediction of Antimicrobial Peptides crea...

Descripción completa

Detalles Bibliográficos
Autores principales: Salem, Milad, Keshavarzi Arshadi, Arash, Yuan, Jiann Shiun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511757/
https://www.ncbi.nlm.nih.gov/pubmed/36163001
http://dx.doi.org/10.1186/s12859-022-04952-z
_version_ 1784797708169510912
author Salem, Milad
Keshavarzi Arshadi, Arash
Yuan, Jiann Shiun
author_facet Salem, Milad
Keshavarzi Arshadi, Arash
Yuan, Jiann Shiun
author_sort Salem, Milad
collection PubMed
description BACKGROUND: Deep learning’s automatic feature extraction has proven to give superior performance in many sequence classification tasks. However, deep learning models generally require a massive amount of data to train, which in the case of Hemolytic Activity Prediction of Antimicrobial Peptides creates a challenge due to the small amount of available data. RESULTS: Three different datasets for hemolysis activity prediction of therapeutic and antimicrobial peptides are gathered and the AMPDeep pipeline is implemented for each. The result demonstrate that AMPDeep outperforms the previous works on all three datasets, including works that use physicochemical features to represent the peptides or those who solely rely on the sequence and use deep learning to learn representation for the peptides. Moreover, a combined dataset is introduced for hemolytic activity prediction to address the problem of sequence similarity in this domain. AMPDeep fine-tunes a large transformer based model on a small amount of peptides and successfully leverages the patterns learned from other protein and peptide databases to assist hemolysis activity prediction modeling. CONCLUSIONS: In this work transfer learning is leveraged to overcome the challenge of small data and a deep learning based model is successfully adopted for hemolysis activity classification of antimicrobial peptides. This model is first initialized as a protein language model which is pre-trained on masked amino acid prediction on many unlabeled protein sequences in a self-supervised manner. Having done so, the model is fine-tuned on an aggregated dataset of labeled peptides in a supervised manner to predict secretion. Through transfer learning, hyper-parameter optimization and selective fine-tuning, AMPDeep is able to achieve state-of-the-art performance on three hemolysis datasets using only the sequence of the peptides. This work assists the adoption of large sequence-based models for peptide classification and modeling tasks in a practical manner.
format Online
Article
Text
id pubmed-9511757
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95117572022-09-27 AMPDeep: hemolytic activity prediction of antimicrobial peptides using transfer learning Salem, Milad Keshavarzi Arshadi, Arash Yuan, Jiann Shiun BMC Bioinformatics Research BACKGROUND: Deep learning’s automatic feature extraction has proven to give superior performance in many sequence classification tasks. However, deep learning models generally require a massive amount of data to train, which in the case of Hemolytic Activity Prediction of Antimicrobial Peptides creates a challenge due to the small amount of available data. RESULTS: Three different datasets for hemolysis activity prediction of therapeutic and antimicrobial peptides are gathered and the AMPDeep pipeline is implemented for each. The result demonstrate that AMPDeep outperforms the previous works on all three datasets, including works that use physicochemical features to represent the peptides or those who solely rely on the sequence and use deep learning to learn representation for the peptides. Moreover, a combined dataset is introduced for hemolytic activity prediction to address the problem of sequence similarity in this domain. AMPDeep fine-tunes a large transformer based model on a small amount of peptides and successfully leverages the patterns learned from other protein and peptide databases to assist hemolysis activity prediction modeling. CONCLUSIONS: In this work transfer learning is leveraged to overcome the challenge of small data and a deep learning based model is successfully adopted for hemolysis activity classification of antimicrobial peptides. This model is first initialized as a protein language model which is pre-trained on masked amino acid prediction on many unlabeled protein sequences in a self-supervised manner. Having done so, the model is fine-tuned on an aggregated dataset of labeled peptides in a supervised manner to predict secretion. Through transfer learning, hyper-parameter optimization and selective fine-tuning, AMPDeep is able to achieve state-of-the-art performance on three hemolysis datasets using only the sequence of the peptides. This work assists the adoption of large sequence-based models for peptide classification and modeling tasks in a practical manner. BioMed Central 2022-09-26 /pmc/articles/PMC9511757/ /pubmed/36163001 http://dx.doi.org/10.1186/s12859-022-04952-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Salem, Milad
Keshavarzi Arshadi, Arash
Yuan, Jiann Shiun
AMPDeep: hemolytic activity prediction of antimicrobial peptides using transfer learning
title AMPDeep: hemolytic activity prediction of antimicrobial peptides using transfer learning
title_full AMPDeep: hemolytic activity prediction of antimicrobial peptides using transfer learning
title_fullStr AMPDeep: hemolytic activity prediction of antimicrobial peptides using transfer learning
title_full_unstemmed AMPDeep: hemolytic activity prediction of antimicrobial peptides using transfer learning
title_short AMPDeep: hemolytic activity prediction of antimicrobial peptides using transfer learning
title_sort ampdeep: hemolytic activity prediction of antimicrobial peptides using transfer learning
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511757/
https://www.ncbi.nlm.nih.gov/pubmed/36163001
http://dx.doi.org/10.1186/s12859-022-04952-z
work_keys_str_mv AT salemmilad ampdeephemolyticactivitypredictionofantimicrobialpeptidesusingtransferlearning
AT keshavarziarshadiarash ampdeephemolyticactivitypredictionofantimicrobialpeptidesusingtransferlearning
AT yuanjiannshiun ampdeephemolyticactivitypredictionofantimicrobialpeptidesusingtransferlearning